Detection Rate and Hospitalizations on the Rise in Korea
Health Authorities Remain on High Alert

As signs of a COVID-19 resurgence emerge in China, health authorities and the medical community in Korea are on high alert.

Getty Images Bank

Getty Images Bank

View original image

According to surveillance data recently released by the Chinese Center for Disease Control and Prevention (CDC), there were 522,000 reported cases of COVID-19 in China from July 1 to 31. Among these, 487 were severe cases, and there was one death. The dominant strain currently spreading in China is the Omicron variant NB.1.8.1.


"Another Wave Begins": 1 in 5 Suspected Patients Test Positive... 522,000 Cases in China, Sharp Surge in Korea in 3 Weeks View original image

The transmission rate is also high among patients with respiratory symptoms. The COVID-19 positivity rate among patients with influenza-like symptoms who visited the outpatient and emergency rooms of 1,041 sample surveillance hospitals across China surged from 8.2% at the end of June to 21.2% at the end of July. This means that one out of every five suspected patients who visited hospitals for COVID-19 or related symptoms tested positive.


A more concerning issue is that the possibility of a COVID-19 resurgence is also increasing in Korea. According to respiratory virus surveillance data for the 33rd week of 2026 from the Korea Disease Control and Prevention Agency, the COVID-19 detection rate for respiratory specimens collected from 106 medical institutions nationwide between August 9 and 15 was 9.1%. This is nearly 2.8 times higher than the 3.2% reported three weeks earlier in the 30th week. Even compared to the previous week (32nd week) at 5.7%, the increase is notable. The number of hospitalized patients at tertiary general hospitals rose from two to seven. Although the scale remains small, experts note that both the rising detection rate and increased hospitalizations warrant close monitoring.


However, although the NB.1.8.1 variant, which accounts for 99% of cases in China, has also been detected in Korea, the main strain currently circulating domestically is known to be BA.3.2.


Meanwhile, experts have stressed the importance of proactive vaccine supply management and compliance with personal hygiene practices, given that it is difficult to predict the scale of outbreaks and referring to cases last year where vaccines ran out early in the vaccination campaign, preventing timely vaccinations for seniors and other high-risk groups. In particular, as vaccine production and supply take time, it is challenging to secure additional doses once an outbreak is in full swing. In fact, Taiwan recently experienced a temporary shortage of vaccines in some regions due to a rapid surge in cases.



This year, the government has secured 4.84 million doses of COVID-19 vaccine. In addition, the new variant-adapted vaccine 'Spikevax Prefilled Syringe Injection' from Moderna received product approval from the Ministry of Food and Drug Safety on August 6.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing